FOXC2在非小细胞肺癌细胞株及组织中的表达及意义 |
| |
引用本文: | 刘曙光,章思思,邹振宁,马红梅,周有俭. FOXC2在非小细胞肺癌细胞株及组织中的表达及意义[J]. 川北医学院学报, 2017, 32(5): 656-658. DOI: 10.3969/j.issn.1005-3697.2017.05.002 |
| |
作者姓名: | 刘曙光 章思思 邹振宁 马红梅 周有俭 |
| |
作者单位: | 中山大学附属第八医院病理科,广东深圳,518033;南方医科大学病理学系,广东广州,510515;广东医科大学病理教研室,广东湛江,524023 |
| |
基金项目: | 深圳市福田区卫生公益性科研项目 |
| |
摘 要: | 目的:研究叉头框C2(Forkhead box c2,FOXC2)在人非小细胞肺癌(non small cell lung cancer,NSCLC)细胞株和组织中的表达水平,并探讨FOXC2与临床病理因素的相关性。方法:应用RT-PCR方法检测FOXC2在人肺癌细胞株A549和H460中mRNA水平的表达情况,并与永生化人支气管上皮细胞株16HBE进行比较;应用免疫组化(IHC)方法检测FOXC2蛋白在66例NSCLC组织和8例癌旁肺组织中的表达情况,并分析FOXC2表达与NSCLC患者临床病理因素的关系。结果:肺癌细胞株A549和H460中FOXC2的mRNA表达水平高于永生化人肺上皮细胞株,差异有统计学意义(P<0.05);FOXC2蛋白在NSCLC组织中表达高于癌旁组织,与肺癌组织淋巴结转移密切相关(P<0.05),而与患者年龄、性别、吸烟、组织学类型、分化程度和TNM分期无明显相关(P>0.05)。结论:FOXC2可能在促进NSCLC的发生和发展过程中发挥了重要的作用,有望作为评估临床肺癌患者预后的指标。
|
关 键 词: | 非小细胞肺癌 FOXC2 细胞株 免疫组织化学 |
Expression of FOXC2 in cell lines and tissues of non small cell lung cancer and its clinical significance |
| |
Abstract: | Objective:To explore the expression of FOXC2 in NSCLC cell lines and tissues,and analyze the correlation between FOXC2 protein expression and clinicopathological factors.Methods:The expressions of FOXC2 mRNA in NSCLC cell lines A549 and H460 were detection by RT-PCR,and 16HBE cell line were compared,Then,the expression of FOXC2 proteins in 66 non small cell lung cancer tissues and 8 paracancerous tissues were determined with immunohistochemical study,and the relationship between the expression of FOXC2 and clinical pathological factors in NSCLC patients was analyzed.Results:The expression levels of FOXC2 mRNA in A549 and H460 cell lines were significantly higher than that in 16HBE cell line,and the difference was statistically significant(P < 0.05).The expression of FOXC2 protein in NSCLC was higher than that in paracancerous tissues,and was closely related to lymph node metastasis in lung cancer tissues (P < 0.05),but was not related to age,gender,smoke history,histological type,differentiation and TNM stage.Conclusion:FOXC2 overexpression may play an important role in the malignant progression of NSCLC,and may be used as an index to evaluate the prognosis of patients with lung cancer. |
| |
Keywords: | Non small cell lung cancer FOXC2 Cell line Immunohistochemistry |
本文献已被 万方数据 等数据库收录! |
|